Inventor · disambiguated record
Victoria Sung
Also filed as: SUNG VICTORIA
5 granted patents·10 pending applications·50 citations·filing 2005–2024
80Inventor score
Top patents by PatentIndex Score
15 records- 0190US7553854B26-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signalingNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Granted Jun 30, 2009·20 cites·78 claims
- 0286US8710048B26-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signalingSUTTON JAMES C·Filed 2012·Granted Apr 29, 2014·12 cites·28 claims
- 0378US10195249B2Activin-ActRII antagonists and uses for treating bone and other disordersCELGENE CORP·Filed 2013·Granted Feb 5, 2019·5 cites·16 claims
- 0477US10548976B2In vitro cell culture methods for beta-thalassemia using activin type II receptor ligand trapsCELGENE CORP·Filed 2016·Granted Feb 4, 2020·3 cites·14 claims
- 0576US8652469B2M-CSF-specific monoclonal antibody and uses thereofKAVANAUGH WILLIAM M·Filed 2006·Granted Feb 18, 2014·10 cites·13 claims
- 0670US2023293634A1Activin-actrii antagonists and uses for treating bone and other disordersCELGENE CORP·Filed 2023·Application pending·0 cites
- 0760US2021371522A1Cd47 antibodies and methods of use thereofCELGENE CORP·Filed 2021·Application pending·0 cites
- 0856US2025249001A1Methods of treating substance use disorder with 4-(3-cyanophenyl)-6-pyridinylpyrimidine mglu5 negative allosteric modulatorsTEMPERO BIO INC·Filed 2024·Application pending·0 cites
- 0952US2020101157A1Vitro cell culture methods for beta-thalassemia using activin type ii receptor ligand trapsCAPPELLINI MARIA·Filed 2019·Application pending·0 cites
- 1052US2019262423A1Activin-actrii antagonists and uses for treating bone and other disordersCELGENE CORP·Filed 2019·Application pending·0 cites
- 1150US2019049469A1Biomarker for use in treating anemiaCELGENE CORP·Filed 2018·Application pending·0 cites
- 1248US2015276766A1Biomarker for use in treating anemiaCELGENE CORP·Filed 2013·Application pending·0 cites
- 1347US2020255515A1Cd47 antibodies and methods of use thereofCELGENE CORP·Filed 2017·Application pending·0 cites
- 1444US2005276757A1Methods of using ZC1 and ZC3 kinase substrate phosphorylation as biomarkersPFIZER·Filed 2005·Application pending·0 cites
- 1537US2015266950A1Methods for treating anemiaCELGENE CORP·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →